https://www.selleckchem.com/pr....oducts/Flavopiridol.
al cardiopulmonary circulation impairment. Adrenal insufficiency (AI) is associated with increased cardiovascular morbidity and mortality and reduced quality of life (QoL). Optimum glucocorticoid (GC) dosing and timing are crucial in the treatment of AI, yet the natural circadian secretion of cortisol is difficult to mimic. The once-daily dual-release hydrocortisone (DR-HC) preparation (Plenadren®), offers a more physiological cortisol profile and may address unmet needs. An investigator-initiated, prospective, cross-over study in
Like
Comment
Share
